Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04079933 · ClinicalTrials.gov registry record · NA
A Study to Evaluate Changes in Smokers Using An Oral Tobacco-Derived Nicotine Product
A NA study, sponsored by Altria Client Services.
- Completed
- Registry status
- NA
- Development phase
- 154
- Enrollment target
NCT04079933 is a NA study that has completed, run by Altria Client Services. The registered enrollment target is 154 participants.
The verdict
NCT04079933, a NA study, has completed, sponsored by Altria Client Services.
- COMPLETED
- Registry status
- NA
- Development phase
- 154 participants
- Enrollment target
Study Summary
The purpose of this study was to estimate changes in biomarkers of exposure (BOE) in adult cigarette smokers using an oral tobacco-derived nicotine (OTDN) product relative to adult smokers who continue smoking exclusively.
Interventions
- OTHER Oral tobacco-derived nicotine product (OTDN)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2013-08-27 |
| Est. Completion | 2013-11-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04079933
The ClinicalTrials.gov registry entry for NCT04079933 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Altria Client Services, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oral tobacco-derived nicotine product (OTDN) is the first listed.
NCT04079933 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04079933 about?
NCT04079933 is a clinical study titled "A Study to Evaluate Changes in Smokers Using An Oral Tobacco-Derived Nicotine Product". The purpose of this study was to estimate changes in biomarkers of exposure (BOE) in adult cigarette smokers using an oral tobacco-derived nicotine (OTDN) product relative to adult smokers who continue smoking exclusively.
What is the current status of trial NCT04079933?
This trial is currently completed. It is a NA study. The enrollment target is 154 participants. The study started on 2013-08-27. Estimated completion is 2013-11-26.
What interventions are being tested in trial NCT04079933?
The interventions under investigation include: Oral tobacco-derived nicotine product (OTDN) (OTHER).
Who is sponsoring clinical trial NCT04079933?
This trial is sponsored by Altria Client Services, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.